Haemonetics (HAE) Tops Q4 EPS by 1c, Offers Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $91.34 --0%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.43, $0.01 better than the analyst estimate of $0.42. Revenue for the quarter came in at $233.6 million versus the consensus estimate of $227.12 million.
GUIDANCE:
Haemonetics sees FY2019 EPS of $2.00-$2.30, versus the consensus of $2.09.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
- Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
